CYTK stock · META stock

CYTK vs META · rev $28.6M vs P/E 29, rev $60.80B

Cytokinetics Inc (CYTK) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.

Cytokinetics Inc (CYTK) is a biotechnology company listed on US.

Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.

Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.

Latest reported META revenue for 2026-06-30 was $60.80B. Net income was $15.85B. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. META currently screens at market cap $1.64T and trailing P/E 28.8.

CYTK currently screens at market cap $4.05B. META currently screens at market cap $1.64T and trailing P/E 28.8.

Not investment advice. Open the CYTK and META stock pages for the full models.

Not investment advice.

Popular Stock Comparisons